Scott Gottlieb is skeptical of the science behind CBD supplements

D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Scott Gottlieb has a lot of thoughts on CBD

When I chatted with the former FDA commissioner about the agency’s efforts to regulate CBD, one thing was crystal clear: Gottlieb probably isn’t going to be offered a job as the head of the CBD lobby any time soon.

“There’s no science to demonstrate that putting it in the food supply has any medicinal value, let alone [to] support that it’s safe. People are just doing it,” Gottlieb told me.

advertisement

Our chat came just after I published a story about the FDA’s quest (or perhaps, its struggle) to regulate CBD, or cannabidiol, in dietary supplements.

Gottlieb, like any good (former) regulator, also emphasized that he believes there’s likely a “pharmaceutical opportunity here,” and listed neurological and neuromuscular disorders

... read more at: https://www.statnews.com/2019/05/21/dc-diagnosis-gottlieb-cbd/

by

Leave a Reply